CERUS CORP
For the period ended Dec 31, 2023. Filed Mar 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 5, 2024
CERS$1.95-5.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEM ENTS OF CASH FLOWS
| Year Ended | |||
|---|---|---|---|
| December 31, | |||
| 2023 | 2022 | 2021 | |
| Operating activities | |||
| Net loss | $(37,647) | $(42,825) | $(54,376) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 2,599 | 2,984 | 3,148 |
| Stock-based compensation | 20,271 | 24,456 | 23,571 |
| Non-cash operating lease cost | 2,308 | 1,575 | 1,422 |
| Changes in valuation of warrant investment | — | 2,183 | (148) |
| Loss (gain), net on sale of available-for-sale securities | 54 | 108 | (21) |
| Unrealized gain on investments | (170) | (564) | (267) |
| Impairment of long-lived assets | — | — | 387 |
| Loss on disposal of fixed assets | 65 | — | — |
| Impairment charges for facilities consolidation | 1,698 | — | — |
| Non-cash interest expense | 374 | 609 | 591 |
| Foreign currency remeasurement (gain) loss | (685) | 1,911 | 511 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (1,102) | (9,200) | (4,215) |
| Inventories | (14,947) | (1,768) | (19,610) |
| Prepaid and other assets | (994) | 1,168 | 2,738 |
| Accounts payable | (7,335) | (4,905) | 12,204 |
| Accrued liabilities and other non-current liabilities | (9,070) | (1,263) | 47 |
| Deferred revenue | 1,413 | (84) | 96 |
| Net cash used in operating activities | (43,168) | (25,615) | (33,922) |
| Investing activities | |||
| Capital expenditures | (4,597) | (2,000) | (910) |
| Purchases of investments | (2,486) | (29,640) | (52,066) |
| Proceeds from maturities and sale of investments | 15,707 | 40,104 | 65,664 |
| Net cash provided by investing activities | 8,624 | 8,464 | 12,688 |
| Financing activities | |||
| Net proceeds from equity incentives | 925 | 4,084 | 9,370 |
| Net (costs) proceeds from public offerings | (175) | (104) | 2,743 |
| Net proceeds on revolving line of credit | 5,091 | 212 | 6,181 |
| Proceeds from loans, net of issuance costs | 4,832 | — | 15,000 |
| Contribution from noncontrolling interest | — | — | 1,000 |
| Net cash provided by financing activities | 10,673 | 4,192 | 34,294 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (128) | (727) | (919) |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (23,999) | (13,686) | 12,141 |
| Cash, cash equivalents, and restricted cash, beginning of period | 37,358 | 51,044 | 38,903 |
| Cash, cash equivalents, and restricted cash, end of period | $13,359 | $37,358 | $51,044 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | $9,210 | $5,100 | $4,181 |
| Cash paid for income taxes | 322 | 270 | 278 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.